Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes

Key Points

• Survivorship outcomes differ significantly, impacting treatment decisions and strategies.
• Long-term survivors demonstrate distinct disease profiles compared to short-term counterparts.
• Observational analysis across multiple cohorts highlights variations in systemic therapy responsiveness.
• Findings underscore the importance of understanding patient-related factors in optimizing treatment.